支气管哮喘治疗的新进展分析  

Analysis of the New Progress in the Treatment of Bronchial Asthma

作　　者：孙雷 于海彤 宫静 贾博宇 李俊萱 李青松 SUN Lei;YU Hai-tong;GONG Jing;JIA Bo-yu;LI Jun-xuan;LI Qing-song(Department of Respiration A Cheng District People ＂s Hospital of Harbin,Harbin,Heilongjian)

机构地区：[1]哈尔滨市阿城区人民医院呼吸科

出　　处：《世界最新医学信息文摘》2018年第27期30-30,32,共2页World Latest Medicine Information Electronic Version

摘　　要：支气管哮喘是临床上常见的慢性肺部疾病,目前全球患有支气管哮喘的患者约有3亿人,且发病率呈逐年上升趋势,严重威胁了人类的健康,同时给患者带来沉重的经济负担。随着医学的发展,治疗支气管哮喘的方案也越来越多,临床上主要以药物治疗为主,还包括基因治疗、免疫调节等。本文主要对支气管哮喘的治疗新进展进行分析总结,以对治疗支气管哮喘的疗效达到提升作用。Bronchial asthma is a common chronic lung disease in clinical practice, at present, there are about 300 million people suffering from bronchial asthma in the world, and the incidence of the disease is increasing year by year, it seriously threatens human health and brings heavy financial burden to patients. With the development of medicine, there are more and more programs for treating bronchial asthma, the main clinical treatment is drug treatment, it also includes gene therapy, immunoregulation, and so on. this article mainly analyzes and summarizes the new progress in the treatment of bronchial asthma, and improves the curative effect of bronchial asthma.

关 键 词：支气管哮喘 发病率 治疗新进展 分析 

分 类 号：R562.25[医药卫生—呼吸系统]